240 mL Water Drink Study
MRI Quantification of Gastric and Small Bowel Liquid Volumes Before and After Ingestion of the Standard Oral Solid Delivery 240 mL Water Drink
調査の概要
詳細な説明
Solid oral delivery is the most frequently used route of administration for pharmaceutical drug products. Along with other important physiological parameters, the volume of liquid in the small intestine (SILV) has the potential to greatly influence the rate and extent of drug dissolution and absorption in the GI tract, or "oral bioperformance". Modeled small bowel absorption of a drug can vary by more than five-fold as SILV decreases from 500 to 50 ml. To obtain reasonable predictions of oral bioperformance scientists must design meaningful in vitro dissolution tests and mechanistic drug transport models that capture the range of SILV in humans. However, little is known about liquid volumes in the gut, mostly due to invasiveness of previous techniques. A recent study has drawn great attention to the possibility of the liquid in the small intestine existing in discrete liquid "pockets" hence it would also be desirable to monitor the time courses and volumes of individual water pockets in the small intestine.
Magnetic resonance imaging (MRI) is the ideal tool to carry out serial and non-invasive imaging of gastrointestinal function. MRI is inherently suited to image liquid materials and this ability has been exploited to image liquids in the undisturbed gastrointestinal tract. Gastric emptying measurements have been long established and validated. Small bowel liquid volumes measurements have been recently validated against naso-duodenal infusion. Ultimately, the findings with this study will provide novel insights on the volume and distribution of ingested liquids in the gastrointestinal tract.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Nottingham、イギリス、NG7 2RD
- University of Nottingham
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Apparently healthy; no medical conditions that might affect the study measurements
- Male or female
- Age between 18 and 55 years of age
- Body mass index (BMI) between 18.5 and 24.9 kg m-2
- Suitable for MRI scanning (eg absence of metal implants, infusion pumps and pacemakers as assessed by the MRI safety questionnaire
Exclusion Criteria:
- Previous gastrointestinal surgery (excluding cholecystectomy and appendectomy)
- Known gastrointestinal disease
- Smoking
- History of alcohol or drug abuse
- Taking medication that is likely to affect gastrointestinal function
- Participation in night shift work the week prior to the study day. (Night work is defined as working between midnight and 6 am)
- Strenuous exercise greater than 10 hours per week
- Consumption of more than 21 units of alcohol in a typical week
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:240 mL water drink
Volunteers will be asked to drink 240 mL water drink
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Time course of small bowel liquid volume after ingesting 240 mL of water
時間枠:0 - 120 mins
|
Time course for the volume of freely mobile water in the small bowel over 2 hours
|
0 - 120 mins
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Time course of gastric liquid volume after ingesting 240 mL of water
時間枠:0 - 120 mins
|
Gastric volumes obtained from MRI as a function of time
|
0 - 120 mins
|
|
Number of liquid pockets in the small bowel
時間枠:0 - 120 mins
|
Assessment of the number of pockets of liquid in the small bowel as seen on the MR images
|
0 - 120 mins
|
|
Volume of liquid pockets in the small bowel
時間枠:0 - 120 mins
|
The volume of freely mobile liquid in each of the liquid pockets identified on the MR image
|
0 - 120 mins
|
|
Summary information on the location of liquid pockets by quadrant
時間枠:0 - 120 mins
|
Details on the distribution of the liquid pockets as seen on the MR images
|
0 - 120 mins
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Kathryn Murray, PhD、University of Nottingham
- 主任研究者:Caroline Hoad, PhD、University of Nottingham
- 主任研究者:Penny Gowland, PhD、University of Nottingham
- 主任研究者:Susan Pritchard, MSc、University of Nottingham
- 主任研究者:Martin Garnett、University of Nottingham
- 主任研究者:Robin Spiller, FRCP、University of Nottingham
- 主任研究者:Gregory Amidon、University of Michigan
- 主任研究者:Gordon Amidon、University of Michigan
- 主任研究者:Deanna Mudie、University of Michigan
- スタディディレクター:Luca Marciani, PhD、University of Nottingham
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- A10012013
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。